Sort
30,917 grants matching “tumor microenvironment”
Hypoxia and Regulatory T cells in Cancer
$312,983Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics
$312,983Ronald J Buckanovich · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBM
$312,874Amy Beth Heimberger · Northwestern University At Chicago · P50 · FY2024 · CA
Regulation of Wnt signaling by LPP3 (PAP2b) during angiogenesis
$312,799Kishore K Wary · University Of Illinois At Chicago · R01 · FY2013 · HL
Cytokine regulation of RA synoviocyte phenotype
$312,775Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2008 · AR
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
$312,768David W. Clapp · Indiana University Indianapolis · R01 · FY2012 · CA
Activation of Intratumoral pDCs by Tumor Self-DNA Coupled with Anti-microbial
$312,764Michel Gilliet · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
Integrative and Quantitative Biosciences Accelerated Training Environment
$312,726Peng Qiu · Georgia Institute Of Technology · T32 · FY2024 · GM
Interpretable deep learning models for translational medicine
$312,719Xinghua Lu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · LM
Reprogramming the TME for immunogenic antigen-presentation
$312,717David H Munn · Augusta University · R01 · FY2024 · CA
Genetic Analysis of Myeloproliferative Disease
$312,717John K Cowell · Augusta University · R01 · FY2024 · CA
Evaluation of therapeutic efficacy and safety of novel small RNA target delivery platform in vivo.
$312,714Martin Devenport · Oncoimmune, Inc. · R41 · FY2019 · OD
Ras/ets-2 Pathway in Breast Cancer Progression
$312,643Michael C Ostrowski · Ohio State University · P01 · FY2008 · CA
Nanoparticle-mediated treatment for bone metastasis
$312,562Vinod D Labhasetwar · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Nanoparticle-mediated treatment for bone metastasis
$312,562Vinod D Labhasetwar · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Nanoparticle-mediated treatment for bone metastasis
$312,562Vinod D Labhasetwar · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
Role of IL10 and TGFb1 in colon cancer
$312,514Susan E. Erdman · Massachusetts Institute Of Technology · R01 · FY2012 · CA
Combinatorial targeting of melanoma initiating cells
$312,510Soldano Ferrone · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA
Molecular Imaging of Chemokine Receptor Signaling
$312,499Gary D Luker · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Chemomodulation of the Tumor Microenvironment
$312,439Michael R Shurin · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Chemomodulation of the Tumor Microenvironment
$312,439Michael R Shurin · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA
Chemomodulation of the Tumor Microenvironment
$312,439Michael R Shurin · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Local Radiation as an Adjuvant for Immunotherapy
$312,389Sandra Demaria · New York University School Of Medicine · R01 · FY2011 · CA
Role of SNF1 Kinase HUNK in breast cancer progression
$312,379Lewis A Chodosh · University Of Pennsylvania · R01 · FY2014 · CA
OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy
$312,375Balveen Kaur · Ohio State University · R01 · FY2012 · NS